Due to a system-wide technology update, we are experiencing extremely high call volume. We appreciate your patience with our operators during this time. Thank you for choosing Fox Chase Cancer Center.
Licensing Samples from Biosample Repository
Fox Chase Cancer Center has established one of the world's leading biosample repositories from which we regularly license well-annotated, fully-consented diseased and normal samples collected under an IRB-approved protocol to industry and academic investigators for research purposes. Sample requestors must contact the technology transfer team to execute a tangible research material license agreement. Once the agreement is executed, we work closely with the biosample repository team to provide you with the requested samples.